US2009093494A1PendingUtilityA1
4-Pyrimidineamine Compounds And Uses As Anti-Proliferative Agents
Est. expiryJun 29, 2024(expired)· nominal 20-yr term from priority
C07D 409/14C07D 413/04C07D 417/14C07D 409/04A61P 35/04C07D 239/47C07D 405/14C07D 239/42C07D 405/12C07D 401/04C07D 413/14A61P 35/00C07D 403/04C07D 405/04
62
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present disclosure provides 4-pyrimidineamine compounds having antiproliferative activity, compositions comprising the compounds and methods of using the compounds to inhibit cellular proliferation and to treat proliferative diseases such as tumorigenic cancers.
Claims
exact text as granted — not AI-modified1 - 24 . (canceled)
25 . A compound selected from the group consisting of:
R 2
R 4′
R 8
R 9
R 10
Cl
Me
H
—O—CH 2 CH 2 —O—
Cl
Me
H
OMe
OMe
Cl
H
—O—CH 2 CH 2 —O—
Cl
Me
H
Cl
Cl
Me
Cl
OMe
Cl
Cl
Me
H
Cl
OMe
Cl
Me
H
OMe
Cl
Cl
Me
H
Cl
Cl
n-Pr
H
OMe
Cl
Cl
Me
OMe
OMe
OMe
Cl
Me
Me
Cl
Me
Cl
Me
OMe
H
OMe
Cl
Me
Cl
OMe
Cl
Cl
Me
H
Cl
CF3
OMe
Me
H
—O—CH 2 CH 2 —O—
Me
H
—O—CH 2 CH 2 —O—
Me
H
—O—CH 2 CH 2 —O—
Me
H
—O—CH 2 CH 2 —O—
Me
H
—O—CH 2 CH 2 —O—
Me
H
—O—CH 2 CH 2 —O—
Me
H
—O—CH 2 CH 2 —O—
Me
H
—O—CH 2 CH 2 —O—
Me
H
—OCH 2 CH 2 —O—
Me
H
—OCH 2 CH 2 —O—
Me
H
—OCH 2 CH 2 —O—
Me
H
—OCH 2 CH 2 —O—
Me
H
—OCH 2 CH 2 —O—
Me
H
—OCH 2 CH 2 —O—
Me
H
—OCH 2 CH 2 —O—
Me
H
—OCH 2 CH 2 —O—
Me
H
—OCH 2 CH 2 —O—
Me
H
—OCH 2 CH 2 —O—
Me
H
—OCH 2 CH 2 —O—
Me
H
—OCH 2 CH 2 —O—
Me
H
—OCH 2 CH 2 —O—
Me
H
—OCH 2 CH 2 —O—
Me
H
—OCH 2 CH 2 —O—
and
Me
H
—OCH 2 CH 2 —O—
26 . A composition comprising a compound according to claim 25 and a pharmaceutically acceptable carrier, excipient and/or diluent.
27 . The composition of claim 26 which is packaged in unit dosage form.
28 . A method of inhibiting proliferation of a breast, colon, pancreatic, lung, bone, or renal tumor cell comprising contacting the cell with an amount of a compound according to claim 25 effective to inhibit its proliferation:
29 . A method of treating a cancer selected from breast cancer, colon cancer, pancreatic cancer, lung cancer, renal cancer, and bone cancer, comprising administering to a subject in need thereof an amount of a compound according to claim 25 effective to treat the proliferative disease.
30 . The method of claim 29 in which the cancer is a metastatic tumor.
31 . The method of claim 29 in which the compound is administered in the form of a pharmaceutical composition.
32 . The method of claim 29 in which the compound is administered orally.
33 . The method of claim 29 in which the compound is administered intravenously.
34 . The method of claim 29 in which the subject is a human.Join the waitlist — get patent alerts
Track US2009093494A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.